Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

Item
http://www.wikidata.org/entity/Q56787356
Vaccination against hepatitis B: current challenges for Asian countries and future directions.Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Weight-based policy of hepatitis B vaccination in very low birth weight infants in Taiwan: a retrospective cross-sectional study.Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008-2009.Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.Effect of inclusion of hepatitis B vaccine in childhood immunization program in India: a retrospective cohort study.Chronic hepatitis B infection in adolescents who received primary infantile vaccination.Molecular, immunological and clinical properties of mutated hepatitis B viruses.Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area.Determination of immune memory to hepatitis B vaccination through early booster response in college students.Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?
P2860

Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

Item
http://www.wikidata.org/entity/Q56787356
description
im Mai 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 1995
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1995
@uk
name
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@nl
type
label
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@nl
prefLabel
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
P2093
P304
P31
P356
10.1016/S0022-3476(95)70398-5
P407
P433
P478
P50
P577
P698